Human Genome Epidemiology Literature Finder
Records 1 - 14 (of 14 Records) |
Query Trace: Lymphoma and RET[original query] |
---|
Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples. Translational oncology 2014 Jun 7 (3): 363-7. Zhao Chao, Li Xuefei, Li Jiayu, Zhang Yishi, Ren Shengxiang, Chen Xiaoxia, Zhou Caic |
Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Sep . Li Shiyong, Choi Yoon-La, Gong Zhuolin, Liu Xiao, Lira Maruja, Kan Zhengyan, Oh Ensel, Wang Jian, Ting Jason C, Ye Xiangsheng, Reinhart Christoph, Liu Xiaoqiao, Pei Yunfei, Zhou Wei, Chen Ronghua, Fu Shijun, Jin Gang, Jiang Awei, Fernandez Julio, Hardwick James, Kang Min Woong, I Hoseok, Zheng Hancheng, Kim Jhingook, Mao M |
EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer. Oncology letters 2016 Apr 11 (4): 2371-2378. Dong Y U, Ren Weihong, Qi Jun, Jin B O, Li Ying, Tao Huiqing, Xu Ren, Li Yanqing, Zhang Qinxian, Han Baoh |
Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma. Cancer 2017 Feb . Tanaka Kosuke, Hida Toyoaki, Oya Yuko, Yoshida Tatsuya, Shimizu Junichi, Mizuno Tetsuya, Kuroda Hiroaki, Sakakura Noriaki, Yoshimura Kenichi, Horio Yoshitsugu, Sakao Yukinori, Yatabe Yasus |
Targeted therapy in nonsmall cell lung cancer. Indian journal of cancer 2017 12 54 (1): 83-88. Puri |
Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study. Virchows Archiv : an international journal of pathology 2018 Apr 472 (4): 581-588. Schwegler Christine, Kaufmann Dinu, Pfeiffer David, Aebi Stefan, Diebold Joachim, Gautschi Oliv |
Sequencing Therapy for Genetically Defined Subgroups of Non-Small Cell Lung Cancer. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018 9 38 726-739. Yu Helena A, Planchard David, Lovly Christine |
Anaplastic lymphoma kinase (ALK) gene rearrangements in radiation-related human papillary thyroid carcinoma after the Chernobyl accident. The journal of pathology. Clinical research 2018 4 4 (3): 175-183. Arndt Annette, Steinestel Konrad, Rump Alexis, Sroya Manveer, Bogdanova Tetiana, Kovgan Leonila, Port Matthias, Abend Michael, Eder Stef |
Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations. Cancer medicine 2019 11 9 (2): 487-495. Wang Huijuan, Wang Ziqi, Zhang Guowei, Zhang Mina, Zhang Xiaojuan, Li Haixia, Zheng Xuanxuan, Ma Zhiyo |
Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study. Endocrine 2020 Jul . Bardet Stéphane, Goardon Nicolas, Lequesne Justine, Vaur Dominique, Ciappuccini Renaud, Leconte Alexandra, Monpeyssen Hervé, Saguet-Rysanek Virginie, Clarisse Bénédicte, Lasne-Cardon Audrey, Ménégaux Fabrice, Leenhardt Laurence, Buffet Camil |
Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients. Frontiers in oncology 2021 4 11 647598. Yang Jie, Li Hefei, Li Ben, Li Wei, Guo Qiang, Hu Ling, Song Zizheng, Zhou B |
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
PD-1 inhibitors plus chemotherapy in EGFR/ALK-positive NSCLC patients with brain metastases and disease progression after EGFR/ALK-TKIs therapy. Journal of cancer research and clinical oncology 2022 7 148 (12): 3557-3566. Zhu Yixiang, Zhang Ye, Hu Xingsheng, Wang Mingzhao, Wang Hongyu, Liu Yut |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: